6th WORKSHOP IRE ON TRANSLATIONAL ONCOLOGY CANCER ORGANOIDS AS RELIABLE DISEASE MODELS TO DRIVE CLINICAL DEVELOPMENT OF NOVEL THERAPIES - 1
×
![]()
Professione e disciplina
- Tutte le Professioni ECM - Tutte le discipline
Allegati
- Programma del Corso Scarica
Informazioni Corso
-
Normativa:
ECM Nazionale -
Obiettivo:
18 Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere
| Crediti: | 8.4 |
| Codice: | 427739 |
| Inizio corso: | 23/09/2024 - dalle: 9:00 |
| Fine corso: | 24/09/2024 - alle: 18:00 |
| Giorni corso previsti: | 2 |
| Totale Ore di formazione: | 12 |
| Iscrizioni: | dal: 02/08/2024 - al: 02/08/2024 |
| Quota partecipazione: | Gratuito |
Location
-
Aula A - Centro Congressi Bastianelli IFO, I.F.O. ISTITUTI FISIOTERAPICI OSPITALIERI
Via Ognibene 23 - Roma
Programma
23/09/2024
3D-BIOPRINTED CANCER MODELS FOR TARGET DISCOVERY, DRUG DEVELOPMENT, AND PERSONALIZED THERAPY - Ronit Satchi-Fainaro
ADVANCES OF PATIENT-DERIVED ORGANOIDS IN PERSONALIZED RADIOTHERAPY- Ingeborg Tinhofer
A 3D CULTURE PLATFORM FOR HIGH-THROUGH PUT DRUG SCREENINGS AND MULTIDIMENSIONAL OMICS AND IMAGING ASSAYS ON PATIENTDERIVED ORGANOIDS - Giovanni Tonon
ADVANCING TUMOROID MODELS THROUGH BIOPRINTING AND BIOMATERIALS DESIGN Sarah C. Heilshorn
MODELING AND MODULATING ANTITUMOR IMMUNITY IN HUMAN CANCER TISSUES Daniela S. Thommen
PERSONALIZED FUNCTIONAL PROFILING - Yong-Jun Kwon
SUPPORT OF MOLECULAR TUMOR BOARD RECOMMENDATIONS THROUGH INSIGHTS FROM ORGANOIDS - Ulrich Keilholz
24/09/2024
09:15 – 09:27 PRECLINICAL MODELS FOR RARE TUMOURS TO ADVANCE PRECISION ONCOLOGY Ana Pestana Charité - Universitätsmedizin Berlin - Berlin, Germany. 09:27 – 09:39 BLADDER-DERIVED TUMOR ORGANOID PLATFORM TO TEST CANCER PRECISION MEDICINE Carlotta Frasc
10:03 – 10:15 CANCER SPHEROIDS AS RELIABLE MODELS FOR DRUG SCREENING: FUNCTIONAL CHARACTERIZATION OF A NEW CLASS OF G-QUADRUPLEX LIGANDS Sara Iachettini IRCCS Regina Elena National Cancer Institute - Rome, Italy 10:1
11:12 – 11:24 ENHANCED PARP INHIBITOR EFFICACY IN 3D HIGH-GRADE SEROUS OVARIAN CANCER MODELS Piera Tocci IRCCS Regina Elena National Cancer Institute - Rome, Italy 11:24 – 11:36 Integrating spatial transcriptomics and organotypic tissue s
MEET THE EDITOR - Gerry Melino
DRUG SCREENING IN TUMOR ORGANOIDS - Giovanni Blandino
DISSECTING PLASTICITY DURING METASTASIS - Karuna Ganesh
INTEGRATION OF MACHINE LEARNING AND PATIENTDERIVED ORGANOIDS INSTRUCTS NEXT-GENERATION PRECISION CANCER MEDICINE - Antonio Iavarone
CONNECTING TOPOLOGY TO FUNCTION IN THE TUMOR ECOSYSTEM - Massimiliano Pagani
UNCOVERING TREATMENT-DRIVEN CHANGES IN BLADDER CANCER: A COMPREHENSIVE OMICS ANALYSIS - Marianna Kruithof-de Julio
PATIENT-DERIVED MICRO-ORGANOIDS ENABLE PRECISION ONCOLOGY - Xiling Shen
CLOSING REMARKS Gennaro Ciliberto - Ulrich Keilholz
14:00 - 14:30
3D-BIOPRINTED CANCER MODELS FOR TARGET DISCOVERY, DRUG DEVELOPMENT, AND PERSONALIZED THERAPY - Ronit Satchi-Fainaro
14:30 - 15:00
ADVANCES OF PATIENT-DERIVED ORGANOIDS IN PERSONALIZED RADIOTHERAPY- Ingeborg Tinhofer
15:00 - 15:30
A 3D CULTURE PLATFORM FOR HIGH-THROUGH PUT DRUG SCREENINGS AND MULTIDIMENSIONAL OMICS AND IMAGING ASSAYS ON PATIENTDERIVED ORGANOIDS - Giovanni Tonon
16:00 - 16:30
ADVANCING TUMOROID MODELS THROUGH BIOPRINTING AND BIOMATERIALS DESIGN Sarah C. Heilshorn
16:30 - 17:00
MODELING AND MODULATING ANTITUMOR IMMUNITY IN HUMAN CANCER TISSUES Daniela S. Thommen
17:00 - 17:30
PERSONALIZED FUNCTIONAL PROFILING - Yong-Jun Kwon
17:30 - 18:00
SUPPORT OF MOLECULAR TUMOR BOARD RECOMMENDATIONS THROUGH INSIGHTS FROM ORGANOIDS - Ulrich Keilholz
24/09/2024
9:15 - 10:00
09:15 – 09:27 PRECLINICAL MODELS FOR RARE TUMOURS TO ADVANCE PRECISION ONCOLOGY Ana Pestana Charité - Universitätsmedizin Berlin - Berlin, Germany. 09:27 – 09:39 BLADDER-DERIVED TUMOR ORGANOID PLATFORM TO TEST CANCER PRECISION MEDICINE Carlotta Frasc
10:00 - 11:00
10:03 – 10:15 CANCER SPHEROIDS AS RELIABLE MODELS FOR DRUG SCREENING: FUNCTIONAL CHARACTERIZATION OF A NEW CLASS OF G-QUADRUPLEX LIGANDS Sara Iachettini IRCCS Regina Elena National Cancer Institute - Rome, Italy 10:1
11:00 - 12:00
11:12 – 11:24 ENHANCED PARP INHIBITOR EFFICACY IN 3D HIGH-GRADE SEROUS OVARIAN CANCER MODELS Piera Tocci IRCCS Regina Elena National Cancer Institute - Rome, Italy 11:24 – 11:36 Integrating spatial transcriptomics and organotypic tissue s
12:00 - 13:00
MEET THE EDITOR - Gerry Melino
14:00 - 14:30
DRUG SCREENING IN TUMOR ORGANOIDS - Giovanni Blandino
14:30 - 15:00
DISSECTING PLASTICITY DURING METASTASIS - Karuna Ganesh
15:00 - 15:30
INTEGRATION OF MACHINE LEARNING AND PATIENTDERIVED ORGANOIDS INSTRUCTS NEXT-GENERATION PRECISION CANCER MEDICINE - Antonio Iavarone
16:00 - 16:30
CONNECTING TOPOLOGY TO FUNCTION IN THE TUMOR ECOSYSTEM - Massimiliano Pagani
16:30 - 17:00
UNCOVERING TREATMENT-DRIVEN CHANGES IN BLADDER CANCER: A COMPREHENSIVE OMICS ANALYSIS - Marianna Kruithof-de Julio
17:00 - 17:30
PATIENT-DERIVED MICRO-ORGANOIDS ENABLE PRECISION ONCOLOGY - Xiling Shen
17:30 - 18:00
CLOSING REMARKS Gennaro Ciliberto - Ulrich Keilholz